management

Insilicos' management team integrates expertise in analytical chemistry, scientific computing, diagnostic medicine, and industrial software.

The team brings decades of relevant experience to computational proteomics, including leading-edge research into analysis of multidimensional chromatography, six patents, and several successful software start-ups.

President Erik Nilsson

Erik Nilsson leads Insilicos and is responsible for strategic direction.

A software background spanning two decades includes management, software technology, and sales and marketing.

Prior to Insilicos, Erik was president of software company GraphiCode, which he sold in 1999 to Mania Technologie AG. Erik then served as a division president for Mania, managing a software development and sales organization spanning three continents.

Erik was Director of Sales and Marketing for Solution Logic. Erik’s experience also includes positions at Tektronix and Mitron.

Erik is a member of the board of the Washington Biotech and Biomedical Association. He sits on the Executive Committee, and chairs the Government Affairs Council.

Chief Scientist Bryan Prazen, PhD

Dr. Prazen directs Insilicos' research program and conducts research in the scientific foundations of Insilicos’ business.

A recognized expert in the field of multidimensional chromatography, Dr. Prazen has specialized in the development of chemometric methods for the analysis of complex samples from biological and environmental systems.

Bryan has held research positions at the University of Washington and DuPont. He has been a visiting scientist at the YKI Institute for Surface Chemistry in Stockholm, Sweden; and at Chiang Mai University in Chiang Mai, Thailand.

VP Informatics Brian Pratt

Brian Pratt is responsible for setting technical direction for software, and leads the development team.

A 20-year software industry veteran, Brian has previously served as VP Engineering for GraphiCode and Senior Developer for WatchGuard Technologies. He holds six issued and two pending biotech patents.

Brian received a BS in electrical engineering and an MS in engineering with a biomedical device focus, both from the University of Washington.